ArticleBlood research2026
Unveiling the role of circulating monocyte-macrophage polarization state and PD-L1/PD-L2 expression in newly diagnosed pediatric ITP.
Article in Blood research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmune thrombocytopenia (ITP) is an immune-mediated disorder characterized by decreased platelet count resulting from immune dysregulation and altered cellular immune responses. This study aimed to evaluate monocyte-macrophage polarization patterns and the expression of immune checkpoint molecules CD273 (PD-L2) and CD274 (PD-L1) in patients with ITP and explore their association with hematological parameters and response to corticosteroid therapy.
methodsThis case-control study compared patients with primary ITP and healthy controls. Hematological indices were assessed using complete blood counts, and monocyte-macrophage subsets including M1-like and M2-like populations and their subtypes (M2a, M2b, and M2c), along with CD273 and CD274 expression were analyzed by flow cytometry.
resultsPatients with ITP showed significantly lower hemoglobin levels, platelet counts, and lymphocyte counts, with higher mean platelet volume (MPV) and platelet distribution width (PDW) compared with controls. A marked increase in M1-like monocyte-macrophages with a concomitant reduction in total M2-like cells was observed in patients with ITP. Within M2 subsets, M2a-like cells were increased, whereas M2b-like and M2c-like subsets were decreased. Expression of CD273 and CD274 were reduced on M1-like cells, and CD273 expression was significantly decreased on M1-like and M2a-like subsets only, with non-significant trends in M2b-like cells. Non-responders to corticosteroid therapy demonstrated higher M1 polarization, increased M2a levels, reduced M2b and M2c subsets, and lower CD273 expression among M1 and M2a compared with responders. Significant correlations were identified between macrophage-like subsets and platelet count, hemoglobin, MPV, and PDW.
conclusionThese findings suggested that a pro-inflammatory M1-like polarization shift combined with an impaired dual PD-L1/PD-L2 checkpoint expression on M2b-like macrophages are significantly correlated with platelet indices and collectively contribute to ITP immunopathogenesis and treatment response, supporting macrophage polarization as a promising immunomodulatory target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.